> top > docs > PubMed:3921269 > annotations

PubMed:3921269 JSONTXT

Annnotations TAB JSON ListView MergeView

spacy-test

Id Subject Object Predicate Lexical cue
spaCy_T0 0-7 NNPS denotes Effects
spaCy_T1 8-10 IN denotes of
spaCy_T2 11-22 NN denotes ellipticine
spaCy_T3 22-23 , denotes ,
spaCy_T4 24-31 NN denotes flavone
spaCy_T5 31-32 , denotes ,
spaCy_T6 33-36 CC denotes and
spaCy_T7 37-53 JJ denotes 7,8-benzoflavone
spaCy_T8 54-58 IN denotes upon
spaCy_T9 59-76 JJ denotes 7,12-dimethylbenz
spaCy_T10 76-77 NNP denotes [
spaCy_T11 77-78 DT denotes a
spaCy_T12 78-79 NNP denotes ]
spaCy_T13 79-89 NN denotes anthracene
spaCy_T14 89-90 , denotes ,
spaCy_T15 91-111 JJ denotes 7,14-dimethyldibenzo
spaCy_T16 111-112 NNP denotes [
spaCy_T17 112-113 DT denotes a
spaCy_T18 113-114 , denotes ,
spaCy_T19 114-115 VBP denotes h
spaCy_T20 115-116 JJ denotes ]
spaCy_T21 116-126 NN denotes anthracene
spaCy_T22 127-130 CC denotes and
spaCy_T23 131-138 NN denotes dibenzo
spaCy_T24 138-139 NNP denotes [
spaCy_T25 139-140 DT denotes a
spaCy_T26 140-141 , denotes ,
spaCy_T27 141-142 VBP denotes h
spaCy_T28 142-143 JJ denotes ]
spaCy_T29 143-153 NN denotes anthracene
spaCy_T30 154-163 VBN denotes initiated
spaCy_T31 164-168 NN denotes skin
spaCy_T32 169-175 NNS denotes tumors
spaCy_T33 176-178 IN denotes in
spaCy_T34 179-183 NNS denotes mice
spaCy_T35 183-184 . denotes .
spaCy_T36 185-192 JJ denotes Varying
spaCy_T37 193-198 NNS denotes doses
spaCy_T38 199-201 IN denotes of
spaCy_T39 202-213 NN denotes ellipticine
spaCy_T40 214-215 -LRB- denotes (
spaCy_T41 215-217 NNP denotes EL
spaCy_T42 217-218 -RRB- denotes )
spaCy_T43 218-219 , denotes ,
spaCy_T44 220-227 VBN denotes flavone
spaCy_T45 228-229 -LRB- denotes (
spaCy_T46 229-231 NNP denotes FL
spaCy_T47 231-232 -RRB- denotes )
spaCy_T48 232-233 , denotes ,
spaCy_T49 234-236 CC denotes or
spaCy_T50 237-253 JJ denotes 7,8-benzoflavone
spaCy_T51 254-255 -LRB- denotes (
spaCy_T52 255-259 NNP denotes 78BF
spaCy_T53 259-260 -RRB- denotes )
spaCy_T54 261-265 VBD denotes were
spaCy_T55 266-273 VBN denotes applied
spaCy_T56 274-276 TO denotes to
spaCy_T57 277-282 NN denotes mouse
spaCy_T58 283-287 NN denotes skin
spaCy_T59 288-289 CD denotes 5
spaCy_T60 290-293 NN denotes min
spaCy_T61 294-300 IN denotes before
spaCy_T62 301-303 DT denotes an
spaCy_T63 304-314 VBG denotes initiating
spaCy_T64 315-319 NN denotes dose
spaCy_T65 320-322 IN denotes of
spaCy_T66 323-325 CD denotes 10
spaCy_T67 326-330 NN denotes nmol
spaCy_T68 331-348 JJ denotes 7,12-dimethylbenz
spaCy_T69 348-349 NNP denotes [
spaCy_T70 349-350 DT denotes a
spaCy_T71 350-351 NNP denotes ]
spaCy_T72 351-361 NN denotes anthracene
spaCy_T73 362-363 -LRB- denotes (
spaCy_T74 363-367 NNP denotes DMBA
spaCy_T75 367-368 -RRB- denotes )
spaCy_T76 368-369 , denotes ,
spaCy_T77 370-374 CD denotes 47.5
spaCy_T78 375-379 NN denotes nmol
spaCy_T79 380-398 JJ denotes 7,14-dimethylbenzo
spaCy_T80 398-399 NNP denotes [
spaCy_T81 399-400 DT denotes a
spaCy_T82 400-401 , denotes ,
spaCy_T83 401-402 VBP denotes h
spaCy_T84 402-403 JJ denotes ]
spaCy_T85 403-413 NN denotes anthracene
spaCy_T86 414-415 -LRB- denotes (
spaCy_T87 415-419 NNP denotes DDBA
spaCy_T88 419-420 -RRB- denotes )
spaCy_T89 420-421 , denotes ,
spaCy_T90 422-424 CC denotes or
spaCy_T91 425-428 CD denotes 200
spaCy_T92 429-433 JJ denotes nmol
spaCy_T93 434-441 NN denotes dibenzo
spaCy_T94 441-442 NNP denotes [
spaCy_T95 442-443 DT denotes a
spaCy_T96 443-444 , denotes ,
spaCy_T97 444-445 VBP denotes h
spaCy_T98 445-446 JJ denotes ]
spaCy_T99 446-456 NN denotes anthracene
spaCy_T100 457-458 -LRB- denotes (
spaCy_T101 458-461 NNP denotes DBA
spaCy_T102 461-462 -RRB- denotes )
spaCy_T103 463-466 CC denotes and
spaCy_T104 467-470 DT denotes the
spaCy_T105 471-482 NN denotes development
spaCy_T106 483-485 IN denotes of
spaCy_T107 486-490 NN denotes skin
spaCy_T108 491-497 NNS denotes tumors
spaCy_T109 498-500 IN denotes in
spaCy_T110 501-504 DT denotes the
spaCy_T111 505-509 NNS denotes mice
spaCy_T112 510-514 RB denotes then
spaCy_T113 515-523 VBN denotes promoted
spaCy_T114 524-526 IN denotes by
spaCy_T115 527-534 JJ denotes topical
spaCy_T116 535-547 NNS denotes applications
spaCy_T117 548-550 IN denotes of
spaCy_T118 551-552 CD denotes 2
spaCy_T119 553-563 NNS denotes micrograms
spaCy_T120 564-600 JJ denotes 12-O-tetradecanoylphorbol-13-acetate
spaCy_T121 601-602 -LRB- denotes (
spaCy_T122 602-605 NNP denotes TPA
spaCy_T123 605-606 -RRB- denotes )
spaCy_T124 606-607 . denotes .
spaCy_T125 608-610 IN denotes As
spaCy_T126 611-619 VBN denotes expected
spaCy_T127 619-620 , denotes ,
spaCy_T128 621-630 NN denotes treatment
spaCy_T129 631-635 IN denotes with
spaCy_T130 636-640 NNP denotes 78BF
spaCy_T131 641-642 -LRB- denotes (
spaCy_T132 642-644 CD denotes 37
spaCy_T133 645-649 NN denotes nmol
spaCy_T134 650-652 CC denotes or
spaCy_T135 653-656 CD denotes 370
spaCy_T136 657-661 NN denotes nmol
spaCy_T137 661-662 -RRB- denotes )
spaCy_T138 663-671 RB denotes markedly
spaCy_T139 672-681 VBD denotes inhibited
spaCy_T140 682-685 DT denotes the
spaCy_T141 686-690 NN denotes skin
spaCy_T142 691-696 NN denotes tumor
spaCy_T143 697-707 NN denotes initiation
spaCy_T144 708-710 IN denotes by
spaCy_T145 711-715 NNP denotes DMBA
spaCy_T146 716-717 -LRB- denotes (
spaCy_T147 717-724 JJR denotes greater
spaCy_T148 725-729 IN denotes than
spaCy_T149 730-732 CD denotes 70
spaCy_T150 732-733 NN denotes %
spaCy_T151 733-734 -RRB- denotes )
spaCy_T152 734-735 . denotes .
spaCy_T153 736-740 NNP denotes High
spaCy_T154 741-746 NNS denotes doses
spaCy_T155 747-749 IN denotes of
spaCy_T156 750-752 NNP denotes FL
spaCy_T157 753-754 -LRB- denotes (
spaCy_T158 754-758 CD denotes 4500
spaCy_T159 759-763 NN denotes nmol
spaCy_T160 763-764 -RRB- denotes )
spaCy_T161 765-767 CC denotes or
spaCy_T162 768-770 NNP denotes EL
spaCy_T163 771-772 -LRB- denotes (
spaCy_T164 772-775 CD denotes 410
spaCy_T165 776-780 NN denotes nmol
spaCy_T166 780-781 -RRB- denotes )
spaCy_T167 782-786 RB denotes also
spaCy_T168 787-796 VBD denotes inhibited
spaCy_T169 797-801 NNP denotes DMBA
spaCy_T170 802-815 NN denotes tumorigenesis
spaCy_T171 816-817 -LRB- denotes (
spaCy_T172 817-819 CD denotes 52
spaCy_T173 819-820 NN denotes %
spaCy_T174 821-824 CC denotes and
spaCy_T175 825-827 CD denotes 82
spaCy_T176 827-828 NN denotes %
spaCy_T177 828-829 , denotes ,
spaCy_T178 830-842 RB denotes respectively
spaCy_T179 842-843 -RRB- denotes )
spaCy_T180 844-847 CC denotes but
spaCy_T181 848-853 JJR denotes lower
spaCy_T182 854-859 NNS denotes doses
spaCy_T183 860-862 IN denotes of
spaCy_T184 863-865 NNP denotes FL
spaCy_T185 866-867 -LRB- denotes (
spaCy_T186 867-870 CD denotes 450
spaCy_T187 871-875 NN denotes nmol
spaCy_T188 875-876 -RRB- denotes )
spaCy_T189 877-879 CC denotes or
spaCy_T190 880-882 NNP denotes EL
spaCy_T191 883-884 -LRB- denotes (
spaCy_T192 884-887 CD denotes 4.1
spaCy_T193 888-892 NN denotes nmol
spaCy_T194 892-893 -RRB- denotes )
spaCy_T195 894-904 VBD denotes stimulated
spaCy_T196 905-909 NNP denotes DMBA
spaCy_T197 910-923 NN denotes tumorigenesis
spaCy_T198 924-925 -LRB- denotes (
spaCy_T199 925-932 JJR denotes greater
spaCy_T200 933-937 IN denotes than
spaCy_T201 938-940 CD denotes 40
spaCy_T202 940-941 NN denotes %
spaCy_T203 941-942 -RRB- denotes )
spaCy_T204 942-943 . denotes .
spaCy_T205 944-946 IN denotes As
spaCy_T206 947-950 VBD denotes was
spaCy_T207 951-954 DT denotes the
spaCy_T208 955-959 NN denotes case
spaCy_T209 960-964 IN denotes with
spaCy_T210 965-969 NNP denotes DMBA
spaCy_T211 970-980 NN denotes initiation
spaCy_T212 980-981 , denotes ,
spaCy_T213 982-985 DT denotes the
spaCy_T214 986-992 JJR denotes higher
spaCy_T215 993-998 NNS denotes doses
spaCy_T216 999-1001 IN denotes of
spaCy_T217 1002-1004 NNP denotes FL
spaCy_T218 1005-1007 CC denotes or
spaCy_T219 1008-1010 NNP denotes EL
spaCy_T220 1011-1020 VBD denotes inhibited
spaCy_T221 1021-1025 NNP denotes DDBA
spaCy_T222 1026-1030 NN denotes skin
spaCy_T223 1031-1044 NN denotes tumorigenesis
spaCy_T224 1045-1048 CC denotes and
spaCy_T225 1049-1052 DT denotes the
spaCy_T226 1053-1058 JJR denotes lower
spaCy_T227 1059-1064 NNS denotes doses
spaCy_T228 1065-1067 IN denotes of
spaCy_T229 1068-1073 DT denotes these
spaCy_T230 1074-1077 CD denotes two
spaCy_T231 1078-1087 NNS denotes modifiers
spaCy_T232 1088-1098 VBD denotes stimulated
spaCy_T233 1099-1102 DT denotes the
spaCy_T234 1103-1107 NNP denotes DDBA
spaCy_T235 1108-1121 NN denotes tumorigenesis
spaCy_T236 1121-1122 . denotes .
spaCy_T237 1123-1125 IN denotes In
spaCy_T238 1126-1134 NN denotes contrast
spaCy_T239 1135-1139 IN denotes with
spaCy_T240 1140-1143 DT denotes the
spaCy_T241 1144-1151 NNS denotes results
spaCy_T242 1152-1156 IN denotes with
spaCy_T243 1157-1161 NNP denotes DMBA
spaCy_T244 1162-1172 NN denotes initiation
spaCy_T245 1172-1173 , denotes ,
spaCy_T246 1174-1183 NN denotes treatment
spaCy_T247 1184-1188 IN denotes with
spaCy_T248 1189-1193 NNP denotes 78BF
spaCy_T249 1194-1195 -LRB- denotes (
spaCy_T250 1195-1198 CD denotes 370
spaCy_T251 1199-1203 NN denotes nmol
spaCy_T252 1204-1206 CC denotes or
spaCy_T253 1207-1211 CD denotes 3700
spaCy_T254 1212-1216 NN denotes nmol
spaCy_T255 1216-1217 -RRB- denotes )
spaCy_T256 1218-1226 RB denotes slightly
spaCy_T257 1227-1235 JJ denotes enhanced
spaCy_T258 1236-1240 NNP denotes DDBA
spaCy_T259 1241-1254 NN denotes tumorigenesis
spaCy_T260 1255-1256 -LRB- denotes (
spaCy_T261 1256-1258 CD denotes 22
spaCy_T262 1258-1259 NN denotes %
spaCy_T263 1260-1263 CC denotes and
spaCy_T264 1264-1265 CD denotes 6
spaCy_T265 1265-1266 NN denotes %
spaCy_T266 1266-1267 , denotes ,
spaCy_T267 1268-1280 RB denotes respectively
spaCy_T268 1280-1281 -RRB- denotes )
spaCy_T269 1281-1282 . denotes .
spaCy_T270 1283-1292 NNP denotes Treatment
spaCy_T271 1293-1297 IN denotes with
spaCy_T272 1298-1300 NNP denotes EL
spaCy_T273 1301-1304 CC denotes and
spaCy_T274 1305-1307 NNP denotes FL
spaCy_T275 1308-1310 IN denotes at
spaCy_T276 1311-1314 DT denotes all
spaCy_T277 1315-1320 NNS denotes doses
spaCy_T278 1321-1327 VBN denotes tested
spaCy_T279 1328-1338 VBD denotes stimulated
spaCy_T280 1339-1342 NNP denotes DBA
spaCy_T281 1343-1356 NN denotes tumorigenesis
spaCy_T282 1357-1358 -LRB- denotes (
spaCy_T283 1358-1363 NN denotes range
spaCy_T284 1364-1368 CD denotes 4-51
spaCy_T285 1368-1369 NN denotes %
spaCy_T286 1369-1370 -RRB- denotes )
spaCy_T287 1370-1371 , denotes ,
spaCy_T288 1372-1377 IN denotes while
spaCy_T289 1378-1387 NN denotes treatment
spaCy_T290 1388-1392 IN denotes with
spaCy_T291 1393-1396 CD denotes 370
spaCy_T292 1397-1401 NN denotes nmol
spaCy_T293 1402-1406 NNP denotes 78BF
spaCy_T294 1407-1415 RB denotes slightly
spaCy_T295 1416-1426 VBD denotes stimulated
spaCy_T296 1427-1430 NNP denotes DBA
spaCy_T297 1431-1444 NN denotes tumorigenesis
spaCy_T298 1445-1446 -LRB- denotes (
spaCy_T299 1446-1448 CD denotes 19
spaCy_T300 1448-1449 NN denotes %
spaCy_T301 1449-1450 -RRB- denotes )
spaCy_T302 1451-1454 CC denotes and
spaCy_T303 1455-1464 NN denotes treatment
spaCy_T304 1465-1469 IN denotes with
spaCy_T305 1470-1474 CD denotes 3700
spaCy_T306 1475-1479 NN denotes nmol
spaCy_T307 1480-1488 RB denotes slightly
spaCy_T308 1489-1498 VBD denotes inhibited
spaCy_T309 1499-1502 NNP denotes DBA
spaCy_T310 1503-1515 NN denotes tumorigensis
spaCy_T311 1516-1517 -LRB- denotes (
spaCy_T312 1517-1518 CD denotes 9
spaCy_T313 1518-1519 NN denotes %
spaCy_T314 1519-1520 -RRB- denotes )
spaCy_T315 1520-1521 . denotes .
spaCy_T316 1522-1525 DT denotes The
spaCy_T317 1526-1533 NNS denotes effects
spaCy_T318 1534-1536 IN denotes of
spaCy_T319 1537-1538 DT denotes a
spaCy_T320 1539-1544 NN denotes range
spaCy_T321 1545-1547 IN denotes of
spaCy_T322 1548-1552 NNP denotes 78BF
spaCy_T323 1553-1558 NNS denotes doses
spaCy_T324 1559-1563 IN denotes upon
spaCy_T325 1564-1568 NN denotes skin
spaCy_T326 1569-1574 NN denotes tumor
spaCy_T327 1575-1585 NN denotes initiation
spaCy_T328 1586-1588 IN denotes by
spaCy_T329 1589-1591 CD denotes 40
spaCy_T330 1592-1596 NN denotes nmol
spaCy_T331 1597-1601 NNP denotes DMBA
spaCy_T332 1602-1606 VBD denotes were
spaCy_T333 1607-1611 RB denotes also
spaCy_T334 1612-1624 VBN denotes investigated
spaCy_T335 1624-1625 . denotes .
spaCy_T336 1626-1631 IN denotes While
spaCy_T337 1632-1635 DT denotes all
spaCy_T338 1636-1641 NNS denotes doses
spaCy_T339 1642-1644 IN denotes of
spaCy_T340 1645-1649 NNP denotes 78BF
spaCy_T341 1650-1656 VBD denotes tested
spaCy_T342 1657-1658 -LRB- denotes (
spaCy_T343 1658-1666 CD denotes 0.37-370
spaCy_T344 1667-1671 NN denotes nmol
spaCy_T345 1671-1672 -RRB- denotes )
spaCy_T346 1673-1682 VBD denotes inhibited
spaCy_T347 1683-1686 DT denotes the
spaCy_T348 1687-1691 NNP denotes DMBA
spaCy_T349 1692-1705 NN denotes tumorigenesis
spaCy_T350 1705-1706 , denotes ,
spaCy_T351 1707-1710 DT denotes the
spaCy_T352 1711-1715 NN denotes dose
spaCy_T353 1716-1724 NN denotes response
spaCy_T354 1725-1728 VBD denotes was
spaCy_T355 1729-1732 RB denotes not
spaCy_T356 1733-1739 JJ denotes linear
spaCy_T357 1739-1740 : denotes ;
spaCy_T358 1741-1750 NN denotes treatment
spaCy_T359 1751-1755 IN denotes with
spaCy_T360 1756-1759 CD denotes 3.7
spaCy_T361 1760-1764 NN denotes nmol
spaCy_T362 1765-1769 NNP denotes 78BF
spaCy_T363 1770-1778 VBD denotes resulted
spaCy_T364 1779-1781 IN denotes in
spaCy_T365 1782-1786 JJR denotes more
spaCy_T366 1787-1797 NNS denotes papillomas
spaCy_T367 1798-1801 IN denotes per
spaCy_T368 1802-1807 NN denotes mouse
spaCy_T369 1808-1809 -LRB- denotes (
spaCy_T370 1809-1814 CD denotes 12.20
spaCy_T371 1814-1815 -RRB- denotes )
spaCy_T372 1816-1820 IN denotes than
spaCy_T373 1821-1824 VBD denotes did
spaCy_T374 1825-1834 NN denotes treatment
spaCy_T375 1835-1839 IN denotes with
spaCy_T376 1840-1846 DT denotes either
spaCy_T377 1847-1851 CD denotes 0.37
spaCy_T378 1852-1856 NN denotes nmol
spaCy_T379 1857-1861 NNP denotes 78BF
spaCy_T380 1862-1863 -LRB- denotes (
spaCy_T381 1863-1867 CD denotes 8.70
spaCy_T382 1867-1868 -RRB- denotes )
spaCy_T383 1869-1871 CC denotes or
spaCy_T384 1872-1874 CD denotes 37
spaCy_T385 1875-1879 NN denotes nmol
spaCy_T386 1880-1884 NNP denotes 78BF
spaCy_T387 1885-1886 -LRB- denotes (
spaCy_T388 1886-1890 CD denotes 5.97
spaCy_T389 1890-1891 -RRB- denotes )
spaCy_T390 1891-1892 . denotes .
spaCy_T391 1893-1895 PRP denotes It
spaCy_T392 1896-1898 VBZ denotes is
spaCy_T393 1899-1908 VBN denotes concluded
spaCy_T394 1909-1913 IN denotes that
spaCy_T395 1914-1923 NNS denotes modifiers
spaCy_T396 1924-1928 JJ denotes such
spaCy_T397 1929-1931 IN denotes as
spaCy_T398 1932-1936 NNP denotes 78BF
spaCy_T399 1936-1937 , denotes ,
spaCy_T400 1938-1940 NNP denotes FL
spaCy_T401 1941-1944 CC denotes and
spaCy_T402 1945-1947 NNP denotes EL
spaCy_T403 1948-1951 MD denotes may
spaCy_T404 1952-1956 VB denotes have
spaCy_T405 1957-1958 DT denotes a
spaCy_T406 1959-1967 JJ denotes variable
spaCy_T407 1967-1968 , denotes ,
spaCy_T408 1969-1983 JJ denotes dose-dependent
spaCy_T409 1984-1990 NN denotes effect
spaCy_T410 1991-1995 IN denotes upon
spaCy_T411 1996-2000 NN denotes skin
spaCy_T412 2001-2006 NN denotes tumor
spaCy_T413 2007-2017 NN denotes initiation
spaCy_T414 2018-2020 IN denotes by
spaCy_T415 2021-2033 JJ denotes carcinogenic
spaCy_T416 2034-2044 JJ denotes polycyclic
spaCy_T417 2045-2061 NNS denotes arylhydrocarbons
spaCy_T418 2061-2062 . denotes .
spaCy_T419 2063-2067 DT denotes Some
spaCy_T420 2068-2080 NNS denotes implications
spaCy_T421 2081-2083 IN denotes of
spaCy_T422 2084-2088 DT denotes this
spaCy_T423 2089-2097 NN denotes proposal
spaCy_T424 2098-2101 VBP denotes are
spaCy_T425 2102-2111 VBN denotes discussed
spaCy_T426 2111-2112 . denotes .
spaCy_R0 spaCy_T0 spaCy_T10 nmod Effects,[
spaCy_R1 spaCy_T1 spaCy_T0 prep of,Effects
spaCy_R2 spaCy_T2 spaCy_T1 pobj ellipticine,of
spaCy_R3 spaCy_T3 spaCy_T2 punct ",",ellipticine
spaCy_R4 spaCy_T4 spaCy_T2 conj flavone,ellipticine
spaCy_R5 spaCy_T5 spaCy_T4 punct ",",flavone
spaCy_R6 spaCy_T6 spaCy_T4 cc and,flavone
spaCy_R7 spaCy_T7 spaCy_T4 conj "7,8-benzoflavone",flavone
spaCy_R8 spaCy_T8 spaCy_T7 prep upon,"7,8-benzoflavone"
spaCy_R9 spaCy_T9 spaCy_T10 compound "7,12-dimethylbenz",[
spaCy_R10 spaCy_T10 spaCy_T16 nmod [,[
spaCy_R11 spaCy_T11 spaCy_T13 det a,anthracene
spaCy_R12 spaCy_T12 spaCy_T13 compound ],anthracene
spaCy_R13 spaCy_T13 spaCy_T10 appos anthracene,[
spaCy_R14 spaCy_T14 spaCy_T13 punct ",",anthracene
spaCy_R15 spaCy_T15 spaCy_T16 compound "7,14-dimethyldibenzo",[
spaCy_R16 spaCy_T16 spaCy_T30 nsubj [,initiated
spaCy_R17 spaCy_T17 spaCy_T21 det a,anthracene
spaCy_R18 spaCy_T18 spaCy_T19 punct ",",h
spaCy_R19 spaCy_T19 spaCy_T21 compound h,anthracene
spaCy_R20 spaCy_T20 spaCy_T21 compound ],anthracene
spaCy_R21 spaCy_T21 spaCy_T16 appos anthracene,[
spaCy_R22 spaCy_T22 spaCy_T21 cc and,anthracene
spaCy_R23 spaCy_T23 spaCy_T24 compound dibenzo,[
spaCy_R24 spaCy_T24 spaCy_T16 conj [,[
spaCy_R25 spaCy_T25 spaCy_T30 mark a,initiated
spaCy_R26 spaCy_T26 spaCy_T27 punct ",",h
spaCy_R27 spaCy_T27 spaCy_T30 prep h,initiated
spaCy_R28 spaCy_T28 spaCy_T30 advmod ],initiated
spaCy_R29 spaCy_T29 spaCy_T30 nsubj anthracene,initiated
spaCy_R30 spaCy_T30 spaCy_T30 ROOT initiated,initiated
spaCy_R31 spaCy_T31 spaCy_T32 compound skin,tumors
spaCy_R32 spaCy_T32 spaCy_T30 dobj tumors,initiated
spaCy_R33 spaCy_T33 spaCy_T30 prep in,initiated
spaCy_R34 spaCy_T34 spaCy_T33 pobj mice,in
spaCy_R35 spaCy_T35 spaCy_T30 punct .,initiated
spaCy_R36 spaCy_T36 spaCy_T37 amod Varying,doses
spaCy_R37 spaCy_T37 spaCy_T55 nsubj doses,applied
spaCy_R38 spaCy_T38 spaCy_T37 prep of,doses
spaCy_R39 spaCy_T39 spaCy_T38 pobj ellipticine,of
spaCy_R40 spaCy_T40 spaCy_T41 punct (,EL
spaCy_R41 spaCy_T41 spaCy_T39 parataxis EL,ellipticine
spaCy_R42 spaCy_T42 spaCy_T41 punct ),EL
spaCy_R43 spaCy_T43 spaCy_T55 punct ",",applied
spaCy_R44 spaCy_T44 spaCy_T55 advcl flavone,applied
spaCy_R45 spaCy_T45 spaCy_T46 punct (,FL
spaCy_R46 spaCy_T46 spaCy_T55 nsubjpass FL,applied
spaCy_R47 spaCy_T47 spaCy_T46 punct ),FL
spaCy_R48 spaCy_T48 spaCy_T46 punct ",",FL
spaCy_R49 spaCy_T49 spaCy_T46 cc or,FL
spaCy_R50 spaCy_T50 spaCy_T46 conj "7,8-benzoflavone",FL
spaCy_R51 spaCy_T51 spaCy_T50 punct (,"7,8-benzoflavone"
spaCy_R52 spaCy_T52 spaCy_T50 appos 78BF,"7,8-benzoflavone"
spaCy_R53 spaCy_T53 spaCy_T50 punct ),"7,8-benzoflavone"
spaCy_R54 spaCy_T54 spaCy_T55 auxpass were,applied
spaCy_R55 spaCy_T55 spaCy_T55 ROOT applied,applied
spaCy_R56 spaCy_T56 spaCy_T55 prep to,applied
spaCy_R57 spaCy_T57 spaCy_T60 nmod mouse,min
spaCy_R58 spaCy_T58 spaCy_T57 dobj skin,mouse
spaCy_R59 spaCy_T59 spaCy_T58 nummod 5,skin
spaCy_R60 spaCy_T60 spaCy_T56 pobj min,to
spaCy_R61 spaCy_T61 spaCy_T55 prep before,applied
spaCy_R62 spaCy_T62 spaCy_T64 det an,dose
spaCy_R63 spaCy_T63 spaCy_T64 amod initiating,dose
spaCy_R64 spaCy_T64 spaCy_T61 pobj dose,before
spaCy_R65 spaCy_T65 spaCy_T64 prep of,dose
spaCy_R66 spaCy_T66 spaCy_T67 nummod 10,nmol
spaCy_R67 spaCy_T67 spaCy_T69 compound nmol,[
spaCy_R68 spaCy_T68 spaCy_T69 compound "7,12-dimethylbenz",[
spaCy_R69 spaCy_T69 spaCy_T65 pobj [,of
spaCy_R70 spaCy_T70 spaCy_T72 det a,anthracene
spaCy_R71 spaCy_T71 spaCy_T72 compound ],anthracene
spaCy_R72 spaCy_T72 spaCy_T69 appos anthracene,[
spaCy_R73 spaCy_T73 spaCy_T74 punct (,DMBA
spaCy_R74 spaCy_T74 spaCy_T72 appos DMBA,anthracene
spaCy_R75 spaCy_T75 spaCy_T74 punct ),DMBA
spaCy_R76 spaCy_T76 spaCy_T72 punct ",",anthracene
spaCy_R77 spaCy_T77 spaCy_T78 nummod 47.5,nmol
spaCy_R78 spaCy_T78 spaCy_T80 compound nmol,[
spaCy_R79 spaCy_T79 spaCy_T80 compound "7,14-dimethylbenzo",[
spaCy_R80 spaCy_T80 spaCy_T81 compound [,a
spaCy_R81 spaCy_T81 spaCy_T85 det a,anthracene
spaCy_R82 spaCy_T82 spaCy_T83 punct ",",h
spaCy_R83 spaCy_T83 spaCy_T85 nmod h,anthracene
spaCy_R84 spaCy_T84 spaCy_T85 amod ],anthracene
spaCy_R85 spaCy_T85 spaCy_T55 dobj anthracene,applied
spaCy_R86 spaCy_T86 spaCy_T85 punct (,anthracene
spaCy_R87 spaCy_T87 spaCy_T85 appos DDBA,anthracene
spaCy_R88 spaCy_T88 spaCy_T87 punct ),DDBA
spaCy_R89 spaCy_T89 spaCy_T85 punct ",",anthracene
spaCy_R90 spaCy_T90 spaCy_T85 cc or,anthracene
spaCy_R91 spaCy_T91 spaCy_T93 nummod 200,dibenzo
spaCy_R92 spaCy_T92 spaCy_T93 compound nmol,dibenzo
spaCy_R93 spaCy_T93 spaCy_T94 compound dibenzo,[
spaCy_R94 spaCy_T94 spaCy_T85 conj [,anthracene
spaCy_R95 spaCy_T95 spaCy_T99 det a,anthracene
spaCy_R96 spaCy_T96 spaCy_T97 punct ",",h
spaCy_R97 spaCy_T97 spaCy_T99 compound h,anthracene
spaCy_R98 spaCy_T98 spaCy_T99 compound ],anthracene
spaCy_R99 spaCy_T99 spaCy_T94 appos anthracene,[
spaCy_R100 spaCy_T100 spaCy_T101 punct (,DBA
spaCy_R101 spaCy_T101 spaCy_T99 appos DBA,anthracene
spaCy_R102 spaCy_T102 spaCy_T101 punct ),DBA
spaCy_R103 spaCy_T103 spaCy_T99 cc and,anthracene
spaCy_R104 spaCy_T104 spaCy_T105 det the,development
spaCy_R105 spaCy_T105 spaCy_T99 conj development,anthracene
spaCy_R106 spaCy_T106 spaCy_T105 prep of,development
spaCy_R107 spaCy_T107 spaCy_T108 compound skin,tumors
spaCy_R108 spaCy_T108 spaCy_T106 pobj tumors,of
spaCy_R109 spaCy_T109 spaCy_T105 prep in,development
spaCy_R110 spaCy_T110 spaCy_T111 det the,mice
spaCy_R111 spaCy_T111 spaCy_T109 pobj mice,in
spaCy_R112 spaCy_T112 spaCy_T113 advmod then,promoted
spaCy_R113 spaCy_T113 spaCy_T111 acl promoted,mice
spaCy_R114 spaCy_T114 spaCy_T113 agent by,promoted
spaCy_R115 spaCy_T115 spaCy_T116 amod topical,applications
spaCy_R116 spaCy_T116 spaCy_T114 pobj applications,by
spaCy_R117 spaCy_T117 spaCy_T116 prep of,applications
spaCy_R118 spaCy_T118 spaCy_T119 nummod 2,micrograms
spaCy_R119 spaCy_T119 spaCy_T117 pobj micrograms,of
spaCy_R120 spaCy_T120 spaCy_T119 amod 12-O-tetradecanoylphorbol-13-acetate,micrograms
spaCy_R121 spaCy_T121 spaCy_T122 punct (,TPA
spaCy_R122 spaCy_T122 spaCy_T120 appos TPA,12-O-tetradecanoylphorbol-13-acetate
spaCy_R123 spaCy_T123 spaCy_T122 punct ),TPA
spaCy_R124 spaCy_T124 spaCy_T55 punct .,applied
spaCy_R125 spaCy_T125 spaCy_T126 mark As,expected
spaCy_R126 spaCy_T126 spaCy_T139 advcl expected,inhibited
spaCy_R127 spaCy_T127 spaCy_T139 punct ",",inhibited
spaCy_R128 spaCy_T128 spaCy_T139 nsubj treatment,inhibited
spaCy_R129 spaCy_T129 spaCy_T128 prep with,treatment
spaCy_R130 spaCy_T130 spaCy_T129 pobj 78BF,with
spaCy_R131 spaCy_T131 spaCy_T133 punct (,nmol
spaCy_R132 spaCy_T132 spaCy_T133 nummod 37,nmol
spaCy_R133 spaCy_T133 spaCy_T130 appos nmol,78BF
spaCy_R134 spaCy_T134 spaCy_T133 cc or,nmol
spaCy_R135 spaCy_T135 spaCy_T136 nummod 370,nmol
spaCy_R136 spaCy_T136 spaCy_T133 conj nmol,nmol
spaCy_R137 spaCy_T137 spaCy_T133 punct ),nmol
spaCy_R138 spaCy_T138 spaCy_T139 advmod markedly,inhibited
spaCy_R139 spaCy_T139 spaCy_T139 ROOT inhibited,inhibited
spaCy_R140 spaCy_T140 spaCy_T143 det the,initiation
spaCy_R141 spaCy_T141 spaCy_T142 compound skin,tumor
spaCy_R142 spaCy_T142 spaCy_T143 compound tumor,initiation
spaCy_R143 spaCy_T143 spaCy_T139 dobj initiation,inhibited
spaCy_R144 spaCy_T144 spaCy_T143 prep by,initiation
spaCy_R145 spaCy_T145 spaCy_T144 pobj DMBA,by
spaCy_R146 spaCy_T146 spaCy_T147 punct (,greater
spaCy_R147 spaCy_T147 spaCy_T149 amod greater,70
spaCy_R148 spaCy_T148 spaCy_T149 quantmod than,70
spaCy_R149 spaCy_T149 spaCy_T150 nummod 70,%
spaCy_R150 spaCy_T150 spaCy_T143 appos %,initiation
spaCy_R151 spaCy_T151 spaCy_T143 punct ),initiation
spaCy_R152 spaCy_T152 spaCy_T139 punct .,inhibited
spaCy_R153 spaCy_T153 spaCy_T154 amod High,doses
spaCy_R154 spaCy_T154 spaCy_T168 nsubj doses,inhibited
spaCy_R155 spaCy_T155 spaCy_T154 prep of,doses
spaCy_R156 spaCy_T156 spaCy_T155 pobj FL,of
spaCy_R157 spaCy_T157 spaCy_T156 punct (,FL
spaCy_R158 spaCy_T158 spaCy_T159 nummod 4500,nmol
spaCy_R159 spaCy_T159 spaCy_T156 appos nmol,FL
spaCy_R160 spaCy_T160 spaCy_T159 punct ),nmol
spaCy_R161 spaCy_T161 spaCy_T156 cc or,FL
spaCy_R162 spaCy_T162 spaCy_T156 conj EL,FL
spaCy_R163 spaCy_T163 spaCy_T165 punct (,nmol
spaCy_R164 spaCy_T164 spaCy_T165 nummod 410,nmol
spaCy_R165 spaCy_T165 spaCy_T162 appos nmol,EL
spaCy_R166 spaCy_T166 spaCy_T154 punct ),doses
spaCy_R167 spaCy_T167 spaCy_T168 advmod also,inhibited
spaCy_R168 spaCy_T168 spaCy_T168 ROOT inhibited,inhibited
spaCy_R169 spaCy_T169 spaCy_T170 compound DMBA,tumorigenesis
spaCy_R170 spaCy_T170 spaCy_T168 dobj tumorigenesis,inhibited
spaCy_R171 spaCy_T171 spaCy_T170 punct (,tumorigenesis
spaCy_R172 spaCy_T172 spaCy_T173 nummod 52,%
spaCy_R173 spaCy_T173 spaCy_T170 appos %,tumorigenesis
spaCy_R174 spaCy_T174 spaCy_T173 cc and,%
spaCy_R175 spaCy_T175 spaCy_T176 nummod 82,%
spaCy_R176 spaCy_T176 spaCy_T173 conj %,%
spaCy_R177 spaCy_T177 spaCy_T176 punct ",",%
spaCy_R178 spaCy_T178 spaCy_T170 appos respectively,tumorigenesis
spaCy_R179 spaCy_T179 spaCy_T170 punct ),tumorigenesis
spaCy_R180 spaCy_T180 spaCy_T168 cc but,inhibited
spaCy_R181 spaCy_T181 spaCy_T182 amod lower,doses
spaCy_R182 spaCy_T182 spaCy_T195 nsubj doses,stimulated
spaCy_R183 spaCy_T183 spaCy_T182 prep of,doses
spaCy_R184 spaCy_T184 spaCy_T183 pobj FL,of
spaCy_R185 spaCy_T185 spaCy_T187 punct (,nmol
spaCy_R186 spaCy_T186 spaCy_T187 nummod 450,nmol
spaCy_R187 spaCy_T187 spaCy_T184 appos nmol,FL
spaCy_R188 spaCy_T188 spaCy_T187 punct ),nmol
spaCy_R189 spaCy_T189 spaCy_T184 cc or,FL
spaCy_R190 spaCy_T190 spaCy_T184 conj EL,FL
spaCy_R191 spaCy_T191 spaCy_T193 punct (,nmol
spaCy_R192 spaCy_T192 spaCy_T193 nummod 4.1,nmol
spaCy_R193 spaCy_T193 spaCy_T184 appos nmol,FL
spaCy_R194 spaCy_T194 spaCy_T193 punct ),nmol
spaCy_R195 spaCy_T195 spaCy_T168 conj stimulated,inhibited
spaCy_R196 spaCy_T196 spaCy_T197 compound DMBA,tumorigenesis
spaCy_R197 spaCy_T197 spaCy_T195 dobj tumorigenesis,stimulated
spaCy_R198 spaCy_T198 spaCy_T197 punct (,tumorigenesis
spaCy_R199 spaCy_T199 spaCy_T201 amod greater,40
spaCy_R200 spaCy_T200 spaCy_T201 quantmod than,40
spaCy_R201 spaCy_T201 spaCy_T202 nummod 40,%
spaCy_R202 spaCy_T202 spaCy_T197 appos %,tumorigenesis
spaCy_R203 spaCy_T203 spaCy_T197 punct ),tumorigenesis
spaCy_R204 spaCy_T204 spaCy_T195 punct .,stimulated
spaCy_R205 spaCy_T205 spaCy_T206 mark As,was
spaCy_R206 spaCy_T206 spaCy_T220 advcl was,inhibited
spaCy_R207 spaCy_T207 spaCy_T208 det the,case
spaCy_R208 spaCy_T208 spaCy_T206 nsubj case,was
spaCy_R209 spaCy_T209 spaCy_T208 prep with,case
spaCy_R210 spaCy_T210 spaCy_T211 compound DMBA,initiation
spaCy_R211 spaCy_T211 spaCy_T209 pobj initiation,with
spaCy_R212 spaCy_T212 spaCy_T220 punct ",",inhibited
spaCy_R213 spaCy_T213 spaCy_T215 det the,doses
spaCy_R214 spaCy_T214 spaCy_T215 amod higher,doses
spaCy_R215 spaCy_T215 spaCy_T220 nsubj doses,inhibited
spaCy_R216 spaCy_T216 spaCy_T215 prep of,doses
spaCy_R217 spaCy_T217 spaCy_T216 pobj FL,of
spaCy_R218 spaCy_T218 spaCy_T217 cc or,FL
spaCy_R219 spaCy_T219 spaCy_T217 conj EL,FL
spaCy_R220 spaCy_T220 spaCy_T220 ROOT inhibited,inhibited
spaCy_R221 spaCy_T221 spaCy_T223 compound DDBA,tumorigenesis
spaCy_R222 spaCy_T222 spaCy_T223 compound skin,tumorigenesis
spaCy_R223 spaCy_T223 spaCy_T220 dobj tumorigenesis,inhibited
spaCy_R224 spaCy_T224 spaCy_T223 cc and,tumorigenesis
spaCy_R225 spaCy_T225 spaCy_T227 det the,doses
spaCy_R226 spaCy_T226 spaCy_T227 amod lower,doses
spaCy_R227 spaCy_T227 spaCy_T232 nsubj doses,stimulated
spaCy_R228 spaCy_T228 spaCy_T227 prep of,doses
spaCy_R229 spaCy_T229 spaCy_T231 det these,modifiers
spaCy_R230 spaCy_T230 spaCy_T231 nummod two,modifiers
spaCy_R231 spaCy_T231 spaCy_T228 pobj modifiers,of
spaCy_R232 spaCy_T232 spaCy_T220 conj stimulated,inhibited
spaCy_R233 spaCy_T233 spaCy_T235 det the,tumorigenesis
spaCy_R234 spaCy_T234 spaCy_T235 compound DDBA,tumorigenesis
spaCy_R235 spaCy_T235 spaCy_T232 dobj tumorigenesis,stimulated
spaCy_R236 spaCy_T236 spaCy_T232 punct .,stimulated
spaCy_R237 spaCy_T237 spaCy_T237 ROOT In,In
spaCy_R238 spaCy_T238 spaCy_T237 pobj contrast,In
spaCy_R239 spaCy_T239 spaCy_T238 prep with,contrast
spaCy_R240 spaCy_T240 spaCy_T241 det the,results
spaCy_R241 spaCy_T241 spaCy_T239 pobj results,with
spaCy_R242 spaCy_T242 spaCy_T241 prep with,results
spaCy_R243 spaCy_T243 spaCy_T244 compound DMBA,initiation
spaCy_R244 spaCy_T244 spaCy_T242 pobj initiation,with
spaCy_R245 spaCy_T245 spaCy_T244 punct ",",initiation
spaCy_R246 spaCy_T246 spaCy_T244 appos treatment,initiation
spaCy_R247 spaCy_T247 spaCy_T244 prep with,initiation
spaCy_R248 spaCy_T248 spaCy_T259 nmod 78BF,tumorigenesis
spaCy_R249 spaCy_T249 spaCy_T251 punct (,nmol
spaCy_R250 spaCy_T250 spaCy_T251 nummod 370,nmol
spaCy_R251 spaCy_T251 spaCy_T248 appos nmol,78BF
spaCy_R252 spaCy_T252 spaCy_T251 cc or,nmol
spaCy_R253 spaCy_T253 spaCy_T254 nummod 3700,nmol
spaCy_R254 spaCy_T254 spaCy_T251 conj nmol,nmol
spaCy_R255 spaCy_T255 spaCy_T251 punct ),nmol
spaCy_R256 spaCy_T256 spaCy_T257 advmod slightly,enhanced
spaCy_R257 spaCy_T257 spaCy_T259 amod enhanced,tumorigenesis
spaCy_R258 spaCy_T258 spaCy_T259 compound DDBA,tumorigenesis
spaCy_R259 spaCy_T259 spaCy_T247 pobj tumorigenesis,with
spaCy_R260 spaCy_T260 spaCy_T259 punct (,tumorigenesis
spaCy_R261 spaCy_T261 spaCy_T262 nummod 22,%
spaCy_R262 spaCy_T262 spaCy_T259 appos %,tumorigenesis
spaCy_R263 spaCy_T263 spaCy_T262 cc and,%
spaCy_R264 spaCy_T264 spaCy_T265 nummod 6,%
spaCy_R265 spaCy_T265 spaCy_T262 conj %,%
spaCy_R266 spaCy_T266 spaCy_T265 punct ",",%
spaCy_R267 spaCy_T267 spaCy_T262 conj respectively,%
spaCy_R268 spaCy_T268 spaCy_T259 punct ),tumorigenesis
spaCy_R269 spaCy_T269 spaCy_T237 punct .,In
spaCy_R270 spaCy_T270 spaCy_T279 nsubj Treatment,stimulated
spaCy_R271 spaCy_T271 spaCy_T270 prep with,Treatment
spaCy_R272 spaCy_T272 spaCy_T271 pobj EL,with
spaCy_R273 spaCy_T273 spaCy_T272 cc and,EL
spaCy_R274 spaCy_T274 spaCy_T272 conj FL,EL
spaCy_R275 spaCy_T275 spaCy_T279 prep at,stimulated
spaCy_R276 spaCy_T276 spaCy_T277 det all,doses
spaCy_R277 spaCy_T277 spaCy_T275 pobj doses,at
spaCy_R278 spaCy_T278 spaCy_T277 acl tested,doses
spaCy_R279 spaCy_T279 spaCy_T279 ROOT stimulated,stimulated
spaCy_R280 spaCy_T280 spaCy_T281 compound DBA,tumorigenesis
spaCy_R281 spaCy_T281 spaCy_T279 dobj tumorigenesis,stimulated
spaCy_R282 spaCy_T282 spaCy_T285 punct (,%
spaCy_R283 spaCy_T283 spaCy_T285 nmod range,%
spaCy_R284 spaCy_T284 spaCy_T285 nummod 4-51,%
spaCy_R285 spaCy_T285 spaCy_T281 appos %,tumorigenesis
spaCy_R286 spaCy_T286 spaCy_T281 punct ),tumorigenesis
spaCy_R287 spaCy_T287 spaCy_T279 punct ",",stimulated
spaCy_R288 spaCy_T288 spaCy_T295 mark while,stimulated
spaCy_R289 spaCy_T289 spaCy_T295 nsubj treatment,stimulated
spaCy_R290 spaCy_T290 spaCy_T289 prep with,treatment
spaCy_R291 spaCy_T291 spaCy_T292 nummod 370,nmol
spaCy_R292 spaCy_T292 spaCy_T293 compound nmol,78BF
spaCy_R293 spaCy_T293 spaCy_T290 pobj 78BF,with
spaCy_R294 spaCy_T294 spaCy_T295 advmod slightly,stimulated
spaCy_R295 spaCy_T295 spaCy_T279 advcl stimulated,stimulated
spaCy_R296 spaCy_T296 spaCy_T297 compound DBA,tumorigenesis
spaCy_R297 spaCy_T297 spaCy_T295 dobj tumorigenesis,stimulated
spaCy_R298 spaCy_T298 spaCy_T300 punct (,%
spaCy_R299 spaCy_T299 spaCy_T300 nummod 19,%
spaCy_R300 spaCy_T300 spaCy_T297 appos %,tumorigenesis
spaCy_R301 spaCy_T301 spaCy_T297 punct ),tumorigenesis
spaCy_R302 spaCy_T302 spaCy_T297 cc and,tumorigenesis
spaCy_R303 spaCy_T303 spaCy_T297 conj treatment,tumorigenesis
spaCy_R304 spaCy_T304 spaCy_T295 prep with,stimulated
spaCy_R305 spaCy_T305 spaCy_T306 nummod 3700,nmol
spaCy_R306 spaCy_T306 spaCy_T304 pobj nmol,with
spaCy_R307 spaCy_T307 spaCy_T308 advmod slightly,inhibited
spaCy_R308 spaCy_T308 spaCy_T295 conj inhibited,stimulated
spaCy_R309 spaCy_T309 spaCy_T310 compound DBA,tumorigensis
spaCy_R310 spaCy_T310 spaCy_T308 dobj tumorigensis,inhibited
spaCy_R311 spaCy_T311 spaCy_T313 punct (,%
spaCy_R312 spaCy_T312 spaCy_T313 nummod 9,%
spaCy_R313 spaCy_T313 spaCy_T310 appos %,tumorigensis
spaCy_R314 spaCy_T314 spaCy_T310 punct ),tumorigensis
spaCy_R315 spaCy_T315 spaCy_T279 punct .,stimulated
spaCy_R316 spaCy_T316 spaCy_T317 det The,effects
spaCy_R317 spaCy_T317 spaCy_T334 nsubjpass effects,investigated
spaCy_R318 spaCy_T318 spaCy_T317 prep of,effects
spaCy_R319 spaCy_T319 spaCy_T320 det a,range
spaCy_R320 spaCy_T320 spaCy_T318 pobj range,of
spaCy_R321 spaCy_T321 spaCy_T320 prep of,range
spaCy_R322 spaCy_T322 spaCy_T323 compound 78BF,doses
spaCy_R323 spaCy_T323 spaCy_T321 pobj doses,of
spaCy_R324 spaCy_T324 spaCy_T317 prep upon,effects
spaCy_R325 spaCy_T325 spaCy_T326 compound skin,tumor
spaCy_R326 spaCy_T326 spaCy_T327 compound tumor,initiation
spaCy_R327 spaCy_T327 spaCy_T324 pobj initiation,upon
spaCy_R328 spaCy_T328 spaCy_T317 prep by,effects
spaCy_R329 spaCy_T329 spaCy_T330 nummod 40,nmol
spaCy_R330 spaCy_T330 spaCy_T331 compound nmol,DMBA
spaCy_R331 spaCy_T331 spaCy_T328 pobj DMBA,by
spaCy_R332 spaCy_T332 spaCy_T334 auxpass were,investigated
spaCy_R333 spaCy_T333 spaCy_T334 advmod also,investigated
spaCy_R334 spaCy_T334 spaCy_T334 ROOT investigated,investigated
spaCy_R335 spaCy_T335 spaCy_T334 punct .,investigated
spaCy_R336 spaCy_T336 spaCy_T341 mark While,tested
spaCy_R337 spaCy_T337 spaCy_T338 det all,doses
spaCy_R338 spaCy_T338 spaCy_T341 nsubj doses,tested
spaCy_R339 spaCy_T339 spaCy_T338 prep of,doses
spaCy_R340 spaCy_T340 spaCy_T339 pobj 78BF,of
spaCy_R341 spaCy_T341 spaCy_T354 advcl tested,was
spaCy_R342 spaCy_T342 spaCy_T344 punct (,nmol
spaCy_R343 spaCy_T343 spaCy_T344 nummod 0.37-370,nmol
spaCy_R344 spaCy_T344 spaCy_T341 parataxis nmol,tested
spaCy_R345 spaCy_T345 spaCy_T344 punct ),nmol
spaCy_R346 spaCy_T346 spaCy_T341 conj inhibited,tested
spaCy_R347 spaCy_T347 spaCy_T349 det the,tumorigenesis
spaCy_R348 spaCy_T348 spaCy_T349 compound DMBA,tumorigenesis
spaCy_R349 spaCy_T349 spaCy_T346 dobj tumorigenesis,inhibited
spaCy_R350 spaCy_T350 spaCy_T354 punct ",",was
spaCy_R351 spaCy_T351 spaCy_T353 det the,response
spaCy_R352 spaCy_T352 spaCy_T353 compound dose,response
spaCy_R353 spaCy_T353 spaCy_T354 nsubj response,was
spaCy_R354 spaCy_T354 spaCy_T358 ccomp was,treatment
spaCy_R355 spaCy_T355 spaCy_T354 neg not,was
spaCy_R356 spaCy_T356 spaCy_T354 acomp linear,was
spaCy_R357 spaCy_T357 spaCy_T358 punct ;,treatment
spaCy_R358 spaCy_T358 spaCy_T363 nsubj treatment,resulted
spaCy_R359 spaCy_T359 spaCy_T358 prep with,treatment
spaCy_R360 spaCy_T360 spaCy_T361 nummod 3.7,nmol
spaCy_R361 spaCy_T361 spaCy_T362 compound nmol,78BF
spaCy_R362 spaCy_T362 spaCy_T359 pobj 78BF,with
spaCy_R363 spaCy_T363 spaCy_T363 ROOT resulted,resulted
spaCy_R364 spaCy_T364 spaCy_T363 prep in,resulted
spaCy_R365 spaCy_T365 spaCy_T366 amod more,papillomas
spaCy_R366 spaCy_T366 spaCy_T364 pobj papillomas,in
spaCy_R367 spaCy_T367 spaCy_T366 prep per,papillomas
spaCy_R368 spaCy_T368 spaCy_T367 pobj mouse,per
spaCy_R369 spaCy_T369 spaCy_T366 punct (,papillomas
spaCy_R370 spaCy_T370 spaCy_T366 appos 12.20,papillomas
spaCy_R371 spaCy_T371 spaCy_T366 punct ),papillomas
spaCy_R372 spaCy_T372 spaCy_T373 mark than,did
spaCy_R373 spaCy_T373 spaCy_T363 advcl did,resulted
spaCy_R374 spaCy_T374 spaCy_T373 dobj treatment,did
spaCy_R375 spaCy_T375 spaCy_T373 prep with,did
spaCy_R376 spaCy_T376 spaCy_T379 det either,78BF
spaCy_R377 spaCy_T377 spaCy_T379 nummod 0.37,78BF
spaCy_R378 spaCy_T378 spaCy_T379 compound nmol,78BF
spaCy_R379 spaCy_T379 spaCy_T375 pobj 78BF,with
spaCy_R380 spaCy_T380 spaCy_T379 punct (,78BF
spaCy_R381 spaCy_T381 spaCy_T379 appos 8.70,78BF
spaCy_R382 spaCy_T382 spaCy_T381 punct ),8.70
spaCy_R383 spaCy_T383 spaCy_T381 cc or,8.70
spaCy_R384 spaCy_T384 spaCy_T385 nummod 37,nmol
spaCy_R385 spaCy_T385 spaCy_T386 compound nmol,78BF
spaCy_R386 spaCy_T386 spaCy_T379 conj 78BF,78BF
spaCy_R387 spaCy_T387 spaCy_T388 punct (,5.97
spaCy_R388 spaCy_T388 spaCy_T386 parataxis 5.97,78BF
spaCy_R389 spaCy_T389 spaCy_T386 punct ),78BF
spaCy_R390 spaCy_T390 spaCy_T363 punct .,resulted
spaCy_R391 spaCy_T391 spaCy_T393 nsubjpass It,concluded
spaCy_R392 spaCy_T392 spaCy_T393 auxpass is,concluded
spaCy_R393 spaCy_T393 spaCy_T393 ROOT concluded,concluded
spaCy_R394 spaCy_T394 spaCy_T404 mark that,have
spaCy_R395 spaCy_T395 spaCy_T404 nsubj modifiers,have
spaCy_R396 spaCy_T396 spaCy_T397 amod such,as
spaCy_R397 spaCy_T397 spaCy_T395 prep as,modifiers
spaCy_R398 spaCy_T398 spaCy_T397 pobj 78BF,as
spaCy_R399 spaCy_T399 spaCy_T398 punct ",",78BF
spaCy_R400 spaCy_T400 spaCy_T398 conj FL,78BF
spaCy_R401 spaCy_T401 spaCy_T400 cc and,FL
spaCy_R402 spaCy_T402 spaCy_T400 conj EL,FL
spaCy_R403 spaCy_T403 spaCy_T404 aux may,have
spaCy_R404 spaCy_T404 spaCy_T393 ccomp have,concluded
spaCy_R405 spaCy_T405 spaCy_T409 det a,effect
spaCy_R406 spaCy_T406 spaCy_T409 amod variable,effect
spaCy_R407 spaCy_T407 spaCy_T409 punct ",",effect
spaCy_R408 spaCy_T408 spaCy_T409 amod dose-dependent,effect
spaCy_R409 spaCy_T409 spaCy_T404 dobj effect,have
spaCy_R410 spaCy_T410 spaCy_T409 prep upon,effect
spaCy_R411 spaCy_T411 spaCy_T412 compound skin,tumor
spaCy_R412 spaCy_T412 spaCy_T413 compound tumor,initiation
spaCy_R413 spaCy_T413 spaCy_T410 pobj initiation,upon
spaCy_R414 spaCy_T414 spaCy_T409 prep by,effect
spaCy_R415 spaCy_T415 spaCy_T417 amod carcinogenic,arylhydrocarbons
spaCy_R416 spaCy_T416 spaCy_T417 amod polycyclic,arylhydrocarbons
spaCy_R417 spaCy_T417 spaCy_T414 pobj arylhydrocarbons,by
spaCy_R418 spaCy_T418 spaCy_T393 punct .,concluded
spaCy_R419 spaCy_T419 spaCy_T420 det Some,implications
spaCy_R420 spaCy_T420 spaCy_T425 nsubjpass implications,discussed
spaCy_R421 spaCy_T421 spaCy_T420 prep of,implications
spaCy_R422 spaCy_T422 spaCy_T423 det this,proposal
spaCy_R423 spaCy_T423 spaCy_T421 pobj proposal,of
spaCy_R424 spaCy_T424 spaCy_T425 auxpass are,discussed
spaCy_R425 spaCy_T425 spaCy_T425 ROOT discussed,discussed
spaCy_R426 spaCy_T426 spaCy_T425 punct .,discussed

oger-json-test

Id Subject Object Predicate Lexical cue
T1 11-22 CHEBI:4776 denotes ellipticine
T2 11-22 C034192 denotes ellipticine
T3 24-31 CHEBI:42491 denotes flavone
T4 24-31 C043562 denotes flavone
T5 37-53 CHEBI:76995 denotes 7,8-benzoflavone
T6 37-53 C011512 denotes 7,8-benzoflavone
T7 59-89 CHEBI:254496 denotes 7,12-dimethylbenz[a]anthracene
T8 79-89 CHEBI:35298 denotes anthracene
T9 79-89 C034020 denotes anthracene
T10 91-126 C045227 denotes 7,14-dimethyldibenzo[a,h]anthracene
T11 116-126 CHEBI:35298 denotes anthracene
T12 116-126 C034020 denotes anthracene
T13 131-153 C026486 denotes dibenzo[a,h]anthracene
T14 143-153 CHEBI:35298 denotes anthracene
T15 143-153 C034020 denotes anthracene
T16 169-175 D009369 denotes tumors
T17 179-183 10095 denotes mice
T18 179-183 D051379 denotes mice
T19 179-183 O89094 denotes mice
T20 179-183 PR:000005054 denotes mice
T21 202-213 CHEBI:4776 denotes ellipticine
T22 202-213 C034192 denotes ellipticine
T23 220-227 CHEBI:42491 denotes flavone
T24 220-227 C043562 denotes flavone
T25 237-253 CHEBI:76995 denotes 7,8-benzoflavone
T26 237-253 C011512 denotes 7,8-benzoflavone
T27 274-282 PR:P48776 denotes to mouse
T28 277-282 D051379 denotes mouse
T29 277-282 10090 denotes mouse
T30 290-293 CVCL_E777 denotes min
T31 331-361 CHEBI:254496 denotes 7,12-dimethylbenz[a]anthracene
T32 351-361 CHEBI:35298 denotes anthracene
T33 351-361 C034020 denotes anthracene
T34 363-367 CHEBI:254496 denotes DMBA
T35 363-367 D015127 denotes DMBA
T36 403-413 CHEBI:35298 denotes anthracene
T37 403-413 C034020 denotes anthracene
T38 415-419 PR:000006340 denotes DDBA
T39 415-419 P33194 denotes DDBA
T40 415-419 Q16531 denotes DDBA
T41 434-456 C026486 denotes dibenzo[a,h]anthracene
T42 446-456 CHEBI:35298 denotes anthracene
T43 446-456 C034020 denotes anthracene
T44 458-461 CHEBI:35299 denotes DBA
T45 458-461 D029503 denotes DBA
T46 458-461 CHEBI:28598 denotes DBA
T47 471-482 GO:0032502 denotes development
T48 491-497 D009369 denotes tumors
T49 505-509 10095 denotes mice
T50 505-509 D051379 denotes mice
T51 505-509 O89094 denotes mice
T52 505-509 PR:000005054 denotes mice
T53 527-534 GO:0003809 denotes topical
T54 548-552 CHEBI:30494 denotes of 2
T55 564-600 CHEBI:37537 denotes 12-O-tetradecanoylphorbol-13-acetate
T56 593-600 CHEBI:30089 denotes acetate
T57 593-600 CHEBI:47622 denotes acetate
T58 602-605 Q5R8J0 denotes TPA
T59 602-605 Q8SQ23 denotes TPA
T60 602-605 CHEBI:15702 denotes TPA
T61 602-605 CHEBI:61432 denotes TPA
T62 602-605 P11214 denotes TPA
T63 602-605 P00750 denotes TPA
T64 602-605 GO:0031299 denotes TPA
T65 602-605 PR:000012825 denotes TPA
T66 602-605 P19637 denotes TPA
T67 602-605 CHEBI:37537 denotes TPA
T68 602-605 Q28198 denotes TPA
T69 691-696 D009369 denotes tumor
T70 711-715 CHEBI:254496 denotes DMBA
T71 711-715 D015127 denotes DMBA
T72 797-801 CHEBI:254496 denotes DMBA
T73 797-801 D015127 denotes DMBA
T74 802-815 D063646 denotes tumorigenesis
T75 880-885 CVCL_0255 denotes EL (4
T76 880-885 PR:Q570B4 denotes EL (4
T77 905-909 CHEBI:254496 denotes DMBA
T78 905-909 D015127 denotes DMBA
T79 910-923 D063646 denotes tumorigenesis
T80 965-969 CHEBI:254496 denotes DMBA
T81 965-969 D015127 denotes DMBA
T82 1021-1025 PR:000006340 denotes DDBA
T83 1021-1025 P33194 denotes DDBA
T84 1021-1025 Q16531 denotes DDBA
T85 1031-1044 D063646 denotes tumorigenesis
T86 1103-1107 PR:000006340 denotes DDBA
T87 1103-1107 P33194 denotes DDBA
T88 1103-1107 Q16531 denotes DDBA
T89 1108-1121 D063646 denotes tumorigenesis
T90 1157-1161 CHEBI:254496 denotes DMBA
T91 1157-1161 D015127 denotes DMBA
T92 1236-1240 PR:000006340 denotes DDBA
T93 1236-1240 P33194 denotes DDBA
T94 1236-1240 Q16531 denotes DDBA
T95 1241-1254 D063646 denotes tumorigenesis
T96 1260-1265 CVCL_CX63 denotes and 6
T97 1339-1342 CHEBI:35299 denotes DBA
T98 1339-1342 D029503 denotes DBA
T99 1339-1342 CHEBI:28598 denotes DBA
T100 1343-1356 D063646 denotes tumorigenesis
T101 1427-1430 CHEBI:35299 denotes DBA
T102 1427-1430 D029503 denotes DBA
T103 1427-1430 CHEBI:28598 denotes DBA
T104 1431-1444 D063646 denotes tumorigenesis
T105 1499-1502 CHEBI:35299 denotes DBA
T106 1499-1502 D029503 denotes DBA
T107 1499-1502 CHEBI:28598 denotes DBA
T108 1569-1574 D009369 denotes tumor
T109 1597-1601 CHEBI:254496 denotes DMBA
T110 1597-1601 D015127 denotes DMBA
T111 1687-1691 CHEBI:254496 denotes DMBA
T112 1687-1691 D015127 denotes DMBA
T113 1692-1705 D063646 denotes tumorigenesis
T114 1733-1739 SO:0000987 denotes linear
T115 1787-1797 D010212 denotes papillomas
T116 1802-1807 D051379 denotes mouse
T117 1802-1807 10090 denotes mouse
T118 1882-1887 CHEBI:65489 denotes BF (5
T119 2001-2006 D009369 denotes tumor